Trials / Recruiting
RecruitingNCT05698446
Comparison of MBR + Suture Tape, MBR, and Anatomic Reconstruction for CLAI in GJL Cases: A Prospective Cohort Study
Comparison of Modified Broström Repair + Suture Tape and Anatomic Reconstruction for CLAI in Chronic Lateral Ankle Instability in Generalized Joint Laxity Cases: A Prospective Cohort Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 114 (estimated)
- Sponsor
- Peking University Third Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
GJL is a risk factor for postoperative recurrent instability following an MBR for CLAI. BPR with suture tape augmentation and anatomic reconstruction may provide more strength and stability. However, BPR with suture tape augmentation may lead to rejection of the suture tape, while anatomic reconstruction may be associated with more trauma. In addition, the outcomes between the BPR with suture tape augmentation and anatomic reconstruction were unknown.
Detailed description
Generalized joint laxity (GJL) is a risk factor for postoperative recurrent instability following an open modified Broström repair (MBR) for chronic lateral ankle instability (CLAI). MBR with suture tape augmentation and anatomic reconstruction may provide more strength and stability. However, BPR with suture tape augmentation may lead to rejection of the suture tape, while anatomic reconstruction may be associated with more trauma. In addition, the outcomes between the BPR with suture tape augmentation and anatomic reconstruction were unknown.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Modified Broström + Suture tape augmentation operation | Patients with CLAI and GJL will accept the Modified Broström + Suture tape augmentation operation |
| PROCEDURE | Anatomic reconstruction operation | Anatomic reconstruction operation |
| PROCEDURE | Open Modified Broström procedure | Open Modified Broström-Gould surgery |
Timeline
- Start date
- 2021-11-01
- Primary completion
- 2025-06-01
- Completion
- 2025-06-01
- First posted
- 2023-01-26
- Last updated
- 2025-04-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05698446. Inclusion in this directory is not an endorsement.